Kirloskar Pneumatic Posts Flat Q1 FY26 Results, Launches New Compressor Product
Kirloskar Pneumatic Company Ltd. (KPCL) reported largely stable financial results for the first quarter of FY26, with revenue from operations at ₹272 crore, compared to ₹275.3 crore in the same period last year. Profit before tax (PBT) stood at ₹36.8 crore, marginally up from ₹35.9 crore in Q1 FY25.
The company's total income for the quarter was ₹280.2 crore, nearly unchanged from ₹279.7 crore in the year-ago period. Profit after tax increased to ₹28.1 crore, up from ₹26.9 crore. EBITDA margin showed a slight improvement at 15.7%.
New order bookings during the quarter were ₹365 crore, lower than in previous quarters. The company attributed this to global uncertainties delaying several large orders. However, the order book as of July 1, 2025, stood at ₹1,725 crore, showing growth from ₹1,624 crore on April 1.
KPCL introduced a new product — 'Tyche,' a semi-hermetic reciprocating compressor aimed at the commercial refrigeration segment. The compressor's motor is produced in-house to manage costs and ensure supply chain efficiency.
The company also began operations at a new foundry in Nashik based on lost foam castings technology, part of its cost-reduction and backward integration strategy. The foundry emphasizes environmental sustainability and circular manufacturing.
Compression systems remain KPCL's primary business, contributing nearly 89% of total revenue.
The company's earnings per share (EPS) for the quarter rose to ₹4.33, up from ₹4.15 in Q1 FY25. KPCL has also started reporting consolidated results including Systems and Components India Private Limited, acquired recently. Comparable data for the acquisition will be available after a full fiscal year.
Ahmedabad Plane Crash
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
7 days ago
- Business Upturn
Tata Power Launches Statewide Rooftop Solar Drive in Pune
Tata Power Renewables has launched the Ghar Ghar Solar campaign in Pune, offering rooftop systems for ₹1,947 and targeting 800 MW capacity addition in Maharashtra over three years. By Riddhima Jain Published on August 13, 2025, 17:27 IST Tata Power Renewables, a subsidiary of Tata Power, has launched its Ghar Ghar Solar campaign in Pune to expand residential rooftop solar adoption across Maharashtra. Marking Independence Day, the company announced a scheme allowing households to own a rooftop solar system for ₹1,947, symbolising the year of India's independence. The plan offers almost full financing, flexible EMIs, and one-year complimentary solar insurance from Tata AIG. Tata Power Solaroof aims to install 800 MW of rooftop solar capacity in Maharashtra over the next three years and plans to add 1,000 channel partners and retailers to strengthen its distribution network. In Pune, the target is to increase capacity by 250 MW from the existing 200 MW. The company also introduced two new products — MySine , a solar plus battery backup system, and Solar Design Spaces , a curated range of 25 aesthetic rooftop installations. 'As part of our Ghar Ghar Solar campaign, we aim to make clean energy accessible, affordable, and aspirational for every Indian household,' said. Ahmedabad Plane Crash
Business Upturn
11-08-2025
- Business Upturn
Taneira Launches GI-Tagged Sarees to Celebrate National Handloom Day
Tata Group's ethnic wear brand Taneira has introduced Geographical Indication (GI)-tagged sarees on National Handloom Day, starting with Banarasi, Chanderi, and Maheshwari weaves. The initiative aims to authenticate origins, protect India's textile heritage, and empower artisans through certified, traceable sourcing. By Riddhima Jain Published on August 11, 2025, 12:09 IST Taneira, the Tata Group's women's ethnic wear brand, has introduced Geographical Indication (GI)-tagged sarees to mark National Handloom Day, aiming to promote authenticity in India's handloom sector and highlight the work of traditional artisans. The first phase of the launch features GI-certified Banarasi, Chanderi, and Maheshwari sarees, with plans to extend coverage to 10 more weaving clusters. GI tags serve as proof that the sarees originate from their respective regions and are crafted by local artisans using traditional methods. Taneira is collaborating with vendor partners and weaving clusters to secure GI certifications, offering documentation assistance, legal guidance, and on-ground support. These sarees will also carry additional quality and authenticity markers, such as the Handloom Mark, Silk Mark, Zari Certification, Khadi Certificate, and Pashmina Certification. 'By partnering with craft clusters and offering certified weaves, including GI-tagged products, we aim to build a transparent supply chain that empowers artisans and enables customers to make informed, conscious choices,' said Ambuj Narayan, CEO of Taneira. Founded in 2017, Taneira works with over 100 weaving clusters across India and operates 18 Weavershala facilities to enhance production techniques while preserving traditional craftsmanship. The brand has expanded to more than 80 stores across 41 cities and offers international online delivery. Ahmedabad Plane Crash
Business Upturn
07-08-2025
- Business Upturn
Emcure Pharmaceuticals Reports Strong Q1 FY26 Results with 16% Revenue Growth and 41% Jump in Profit
Emcure Pharmaceuticals reported a strong Q1 FY26 performance with a 15.7% YoY rise in revenue to ₹2,101 crore and a 41% jump in PAT to ₹215 crore. Robust growth was seen across both domestic and international markets, supported by new launches and an expanded partnership with Sanofi. 'We delivered robust performance across all businesses in Q1,' said Satish Mehta, CEO and MD, Emcure Pharmaceuticals. By Riddhima Jain Published on August 7, 2025, 15:37 IST Emcure Pharmaceuticals Ltd. (BSE: 544210, NSE: EMCURE) has reported a robust start to FY26, with its consolidated revenue for Q1 reaching ₹2,101 crore, a 15.7% year-on-year (YoY) growth, and profit after tax (PAT) rising by 41% YoY to ₹215 crore. The strong quarterly performance was driven by solid growth across both domestic and international markets. The company's EBITDA grew by 20.1% YoY to ₹404 crore, with EBITDA margins improving to 19.2%. Emcure's international business remained a key growth driver, clocking ₹1,106 crore in sales, up 22.1% YoY, led by strong performances in the Rest of the World (up 41.9%), Canada (up 16.4%), and Europe (up 12.8%). On the domestic front, revenues reached ₹995 crore, registering a 9.4% YoY growth, aided by continued momentum across key therapeutic areas and new initiatives in dermatology and OTC segments. The company also strengthened its portfolio through an expanded partnership with Sanofi, which now includes the Oral Anti-diabetic portfolio in addition to the cardiovascular segment. Satish Mehta, CEO and Managing Director, Emcure Pharmaceuticals Ltd., said: 'We delivered robust performance across all businesses in Q1. We continue to augment our portfolio in all our focus markets though in-licensing and in-house development. The expanded Sanofi partnership positions us well in the fast-growing metabolic segment. We also have a strong product pipeline for both our domestic and international markets which will fuel future growth. We remain focused on improving efficiencies to drive sustained improvement in margins.' Key Financial Highlights – Q1 FY26 (Consolidated): Revenue from operations: ₹2,101 crore vs ₹1,815 crore (↑15.7% YoY) EBITDA: ₹404 crore vs ₹336 crore (↑20.1% YoY); margin at 19.2% PAT: ₹215 crore vs ₹153 crore (↑41% YoY); PAT margin at 10.2% Domestic revenue: ₹995 crore (↑9.4% YoY) International revenue: ₹1,106 crore (↑22.1% YoY) Emcure continues to prioritize R&D and portfolio expansion to drive long-term growth across geographies. With presence in over 70 countries, including strong markets in Europe and Canada, the company is well-positioned to leverage future opportunities in both regulated and emerging markets. Ahmedabad Plane Crash
